본문 바로가기 주메뉴 바로가기 하단메뉴 바로가기

GC녹십자MS

  • Contact / Q&A
  • recruitment
  • KOREA
  • SITEMAP
  • Company Introduction
  • Product Information
  • R&D
  • CSR
  • INVESTORS
 

R&D

With the goal of achieving ‘customer-oriented R&D’, we are focusing on establishing future technologies by expanding and deepening existing technologies.

R&D Fields

Print

Molecular Diagnosis

With the increasing demands and importance of diagnosis, various diagnostic methods have been studied and developed. The market has a growing need for kits with higher accuracy and sensitivity. Under these circumstances, GCMS has recognized a need of development of molecular diagnostic products with higher accuracy and sensitivity, in addition to its existing immunodiagnostic development. In particular, the 2009 H1N1 influenza pandemic led to an explosive growth in the molecular diagnosis market, increasing the market size by 15% yearly. On that ground, GCMS started R&D in molecular diagnostic reagents in 2010 and has established its product lineup for molecular diagnostic kits.